Source : Medtech Insight
The US Food and Drug Administration is continuing its run of virtual town halls aimed at labs and manufacturers that are (or have) developed diagnostic tests for COVID-19.
The FDA announced on 31 March that it will extend its town hall series on the regulation and development of diagnostics for the novel coronavirus through the end of April.
The agency has held 46 of the webinars since March 2020. (Click here for replays and transcripts of each of those meetings.)
The next four town halls will take place on 7, 14, 21 and 28 April. All of them will begin at 12:15 pm EST and be an hour in length. Registration isn’t necessary.
Here’s the dial-in information:
US callers: 888-455-1392; conference No. RWXW2037387; passcode: 9482869
International callers: 1-773-799-3847; conference No. RWXW2037387; passcode: 9482869
The FDA says attendees should visit https://www.mymeetings.com/nc/join.php?i=RWXW2037387&p=9482869&t=c to view the slide presentation during the webinar.
By Shawn M. Schmitt